Achieve Life Sciences Files 8-K on Security Holder Vote Matters
Ticker: ACHV · Form: 8-K · Filed: Jun 6, 2025 · CIK: 949858
| Field | Detail |
|---|---|
| Company | Achieve Life Sciences, Inc. (ACHV) |
| Form Type | 8-K |
| Filed Date | Jun 6, 2025 |
| Risk Level | medium |
| Sentiment | neutral |
Sentiment: neutral
Topics: corporate-governance, shareholder-vote, filing-update
Related Tickers: ACHV
TL;DR
ACHV filed an 8-K for a shareholder vote - big decisions ahead.
AI Summary
On June 4, 2025, Achieve Life Sciences, Inc. filed an 8-K report detailing a submission of matters to a vote of security holders. The company, formerly known as OncoGenex Pharmaceuticals Inc. and Sonus Pharmaceuticals Inc., is incorporated in Delaware and headquartered in Bothell, WA.
Why It Matters
This filing indicates that Achieve Life Sciences is seeking approval from its shareholders on important corporate matters, which could impact the company's future direction and shareholder rights.
Risk Assessment
Risk Level: medium — Filings related to shareholder votes often involve significant corporate actions that can materially affect the company's stock price and future prospects.
Key Numbers
- 033-80623 — SEC File Number (Identifies the company's filing with the SEC.)
- 95-4343413 — IRS Employer Identification No. (Company's tax identification number.)
Key Players & Entities
- Achieve Life Sciences, Inc. (company) — Registrant
- June 4, 2025 (date) — Date of earliest event reported
- Delaware (jurisdiction) — State of Incorporation
- Bothell, WA (location) — Address of Principal Executive Offices
- OncoGenex Pharmaceuticals Inc. (company) — Former Company Name
- Sonus Pharmaceuticals Inc (company) — Former Company Name
FAQ
What specific matters are being submitted for a vote by security holders?
The filing states it is a 'Submission of Matters to a Vote of Security Holders' but does not specify the exact proposals in the provided text.
When was the earliest event reported in this 8-K filing?
The earliest event reported was on June 4, 2025.
What is the primary business address of Achieve Life Sciences, Inc.?
The primary business address is 22722 29th Drive SE, Suite 100, Bothell, WA 98021.
What were the previous names of Achieve Life Sciences, Inc.?
The company was formerly known as OncoGenex Pharmaceuticals, Inc. and Sonus Pharmaceuticals Inc.
In which U.S. state is Achieve Life Sciences, Inc. incorporated?
Achieve Life Sciences, Inc. is incorporated in Delaware.
Filing Details
This Form 8-K (Form 8-K) was filed with the SEC on June 6, 2025 regarding ACHIEVE LIFE SCIENCES, INC. (ACHV).